Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
78.14
-3.03 (-3.73%)
At close: Jan 14, 2025, 4:00 PM
78.10
-0.04 (-0.05%)
After-hours: Jan 14, 2025, 5:01 PM EST
Vaxcyte Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Vaxcyte stock have an average target of 149.38, with a low estimate of 129 and a high estimate of 175. The average target predicts an increase of 91.17% from the current stock price of 78.14.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Vaxcyte stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 4 | 4 | 4 | 5 | 5 |
Buy | 1 | 3 | 3 | 3 | 3 | 3 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 8 | 8 | 8 | 9 | 9 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Goldman Sachs | Goldman Sachs | Strong Buy Initiates $135 | Strong Buy | Initiates | $135 | +72.77% | Dec 20, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 6, 2024 |
Needham | Needham | Strong Buy Reiterates $140 | Strong Buy | Reiterates | $140 | +79.17% | Nov 6, 2024 |
Mizuho | Mizuho | Buy Maintains $113 → $163 | Buy | Maintains | $113 → $163 | +108.60% | Sep 10, 2024 |
B of A Securities | B of A Securities | Strong Buy Maintains $101 → $140 | Strong Buy | Maintains | $101 → $140 | +79.17% | Sep 4, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.15
from -4.14
EPS Next Year
-4.80
from -4.15
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | n/a | |||
Avg | n/a | n/a | n/a | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -3.88 | -3.89 | -2.79 | |||
Avg | -4.15 | -4.80 | -5.26 | |||
Low | -4.85 | -6.88 | -8.70 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.